Interactions of STATs with Src Family Kinases

作者: Corinne M. Silva , Julie L. Boerner , Sarah J. Parsons

DOI: 10.1007/978-94-017-3000-6_15

关键词: KinaseTyrosine kinaseProto-oncogene tyrosine-protein kinase SrcChemistrySH3 domainSH2 domainCell biologyTyrosine phosphorylationLYNProtein kinase domain

摘要: C-Src tyrosine kinase is the cellular homologue of v-Src, oncogenic form protein encoded by chicken retrovirus, Rous sarcoma virus (reviewed in 1, 2). The Src family kinases includes Src, Yes, Yrk, and Fyn which are ubiquitously expressed, Hck, Fgr, Lyn, Lck Blk expressed predominantly hematopoetic cells (myeloid B T lymphocytes). These proteins approximately 60kDa molecular weight composed six domains (Figure 1). For these are: 1) N-terminal domain that contains a signal for myristolyation targets cytosolic to intracellular membranes; 2) unique likely involved protein-protein interactions; 3) an SH3 binds proline-rich sequences; 4) SH2 phosphotyrosine residues; 5) catalytic domain; 6) negative regulatory region at C-terminus Tyr530 (originally identified c-Src as Tyr527). phosphorylated C-terminal (Csk), resulting intramolecular interaction between this thus rendering catalytically inactive. Displacement binding another protein, dephosphorylation, or mutation/deletion (as v-Src) changes conformation c-Src, activation. plays integral role growth factor-induced proliferation well initiation progression many human cancers, differentiation (1, 3, 4). This chapter will review current knowledge regarding interactions (and members) STAT proteins, including association with phosphorylation STATs (SFKs), SFKs activation factors, finally, biological effects require

参考文章(65)
Jacqueline S. Biscardi, David A. Tice, Sarah J. Parsons, c-Src, Receptor Tyrosine Kinases, and Human Cancer Advances in Cancer Research. ,vol. 76, pp. 61- 119 ,(1999) , 10.1016/S0065-230X(08)60774-5
R Jove, DJ Fujita, KL Nelson, A Hudnall, R Catlett, T Smithgall, SP Ethier, R Garcia, CL Yu, Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells Cell Growth & Differentiation. ,vol. 8, pp. 1267- 1276 ,(1997)
T C Lund, R Garcia, M M Medveczky, R Jove, P G Medveczky, Activation of STAT transcription factors by herpesvirus Saimiri Tip-484 requires p56lck. Journal of Virology. ,vol. 71, pp. 6677- 6682 ,(1997) , 10.1128/JVI.71.9.6677-6682.1997
A B Tuck, A Boag, B E Elliott, E E Sterns, M Park, Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. American Journal of Pathology. ,vol. 148, pp. 225- 232 ,(1996)
S J Burakoff, C L Yu, R Jove, Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase. Journal of Immunology. ,vol. 159, pp. 5206- 5210 ,(1997)
Kristie L. Nelson, Jim A. Rogers, Tammy L. Bowman, Richard Jove, Thomas E. Smithgall, Activation of STAT3 by the c-Fes Protein-tyrosine Kinase Journal of Biological Chemistry. ,vol. 273, pp. 7072- 7077 ,(1998) , 10.1074/JBC.273.12.7072
Haiying Liang, Virginia J. Venema, Xiaodan Wang, Hong Ju, Richard C. Venema, Mario B. Marrero, Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells. Journal of Biological Chemistry. ,vol. 274, pp. 19846- 19851 ,(1999) , 10.1074/JBC.274.28.19846
Alexander V. Kazansky, Elena B. Kabotyanski, Shannon L. Wyszomierski, Michael A. Mancini, Jeffrey M. Rosen, Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A. Journal of Biological Chemistry. ,vol. 274, pp. 22484- 22492 ,(1999) , 10.1074/JBC.274.32.22484